Skip to main content

Table 2 Patient demographics

From: The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis

  Overall, N = 1015 No self-reported anxiety/depression, n = 625 Self-reported anxiety/depression, n = 390 P-value (atest)
Patient age, years
 Mean (SD) 55.2 (14.1) 54.3 (14.6) 56.7 (13.1) .012 (MW)
Gender, n (%)
 Female 733 (72.2) 431 (69.0) 302 (77.4) .004 (FE)
Years since RA diagnosis
 Mean, years (SD) 7.5 (7.4) 6.7 (7.0) 8.7 (7.9) .001 (MW)
bMissing, n 69 38 31  
Current severity level, n (%)
 Mild 682 (67.2) 479 (76.6) 203 (52.1)  
 Moderate 294 (29.0) 138 (22.1) 156 (40.0)  
 Severe 39 (3.8) 8 (1.3) 31 (7.9) <.001 (MW)
Current pain level (1–10)
 Mean (SD) 3.3 (2.0) 2.8 (1.7) 4.1 (2.2) <.001 (MW)
On biologic therapy, n (%)
Receiving biologic therapy/on break but expected to restart 469 (46.2)
20 (2.0)
264 (42.2)
10 (1.6)
205 (52.6)
10 (2.6)
.002 (FE)
Discontinued biologic, n (%) 30 (3.0) 16 (2.6) 14 (3.6) 0.636 (PC)
  1. FE Fisher’s exact test; MW Mann-Whitney’s U test; PC Pearson’s Chi-square test; RA rheumatoid arthritis; SD standard deviation
  2. aIndicates statistical test performed
  3. bNumber of patients for whom data were not reported